Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
medicare
2
×
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
brain training
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
dementia
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
disease
drug prices
eddingpharm
eli lilly
What
companies
earlier
2
×
new
alzheimer’s
approval
attention
bio
biogen’s
biopharmaceutical
boon
cash
closed
convo
costs
diagnose
diagnosis
disease
drug
early
failures
fin
funding
gaining
help
littered
million
nash
neurotrack
news
onset
prevent
preventative
price
raise
remains
road
roundup
soar
startups
strategy
Language
Current search:
earlier
×
medicare
×
@techcrunch.com
4 years ago
As Alzheimer’s costs soar, startups like Neurotrack raise cash to diagnose and treat the disease
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
